Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Elgin Hoffmann"'
Autor:
Vlatko Potkrajcic, Cihan Gani, Stefan Georg Fischer, Simon Boeke, Maximilian Niyazi, Daniela Thorwarth, Otilia Voigt, Moritz Schneider, David Mönnich, Sarah Kübler, Jessica Boldt, Elgin Hoffmann, Frank Paulsen, Arndt-Christian Mueller, Daniel Wegener
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2679-2688 (2024)
The use of hypofractionated radiotherapy in prostate cancer has been increasingly evaluated, whereas accumulated evidence demonstrates comparable oncologic outcomes and toxicity rates compared to normofractionated radiotherapy. In this prospective st
Externí odkaz:
https://doaj.org/article/3377eb4abed845409975d69348b5be1b
Autor:
Sebastian H. Maier, Stephan Schönecker, Vasiliki Anagnostatou, Sylvia Garny, Alexander Nitschmann, Daniel F. Fleischmann, Marcel Büttner, David Kaul, Detlef Imhoff, Emmanouil Fokas, Clemens Seidel, Peter Hau, Oliver Kölbl, Ilinca Popp, Anca-Ligia Grosu, Jan Haussmann, Wilfried Budach, Eren Celik, Klaus-Henning Kahl, Elgin Hoffmann, Ghazaleh Tabatabai, Frank Paulsen, Adrien Holzgreve, Nathalie L. Albert, Ulrich Mansmann, Stefanie Corradini, Claus Belka, Maximilian Niyazi, Raphael Bodensohn
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 47, Iss , Pp 100790- (2024)
Background: The PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06; NCT05871021) is designed to determine whether a dose escalation with 75.0 Gy in 30 fractions can enhance the median overall survival (OS) in patients with methylguanine methyltransferase (M
Externí odkaz:
https://doaj.org/article/e593b5076b1b4d3582a15845aa79e307
Autor:
Raphael Bodensohn, Daniel F. Fleischmann, Sebastian H. Maier, Vasiliki Anagnostatou, Sylvia Garny, Alexander Nitschmann, Marcel Büttner, Johannes Mücke, Stephan Schönecker, Kristian Unger, Elgin Hoffmann, Frank Paulsen, Daniela Thorwarth, Adrien Holzgreve, Nathalie L. Albert, Stefanie Corradini, Ghazaleh Tabatabai, Claus Belka, Maximilian Niyazi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 45, Iss , Pp 100706- (2024)
Background and purpose: The PRIDE trial (NOA-28; ARO-2022-12; NCT05871021) is scheduled to start recruitment in October 2023. Its primary objective is to enhance median overall survival (OS), compared to historical median OS rates, in patients with m
Externí odkaz:
https://doaj.org/article/2e39a454d584431f845c26def0ecbd15
Autor:
Elgin Hoffmann, Kerstin Clasen, Bettina Frey, Jakob Ehlers, Felix Behling, Marco Skardelly, Benjamin Bender, Jens Schittenhelm, Matthias Reimold, Ghazaleh Tabatabai, Daniel Zips, Franziska Eckert, Frank Paulsen
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-13 (2021)
Abstract Background Atypical meningiomas exhibit a high tendency for tumor recurrence even after multimodal therapy. Information regarding recurrence patterns after additive radiotherapy is scarce but could improve radiotherapy planning and therapy d
Externí odkaz:
https://doaj.org/article/76420b97bb534773bb03eef51ddf9315
Publikováno v:
Neurological Research and Practice, Vol 1, Iss 1, Pp 1-3 (2019)
Abstract Acute febrile neutrophilic dermatosis (Sweet‘s syndrome) is a dermatological entity, which may be associated with malignancies, drugs, and infections and which is characterized by high fever, elevated neutrophils, and tender erythematous s
Externí odkaz:
https://doaj.org/article/9e24f5f161ae4d73a7b310181773ec86
Autor:
Anne Martinelli, Elgin Hoffmann, Carolin Brück, Benjamin Kreifelts, Thomas Ethofer, Dirk Wildgruber
Publikováno v:
Journal of Neural Transmission. 130:585-596
Laughter plays an important role in group formation, signaling social belongingness by indicating a positive or negative social intention towards the receiver. In adults without autism, the intention of laughter can be correctly differentiated withou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7b987b6cd86cc3ffaafe6ed91cedc4a
https://doi.org/10.1007/s00702-023-02599-5
https://doi.org/10.1007/s00702-023-02599-5
Autor:
Elgin Hoffmann, Chiara De-Colle, Vlatko Potkrajcic, David Baumann, Werner Spengler, Cihan Gani, David Utz
Publikováno v:
Strahlentherapie und Onkologie.
Purpose Extensive-stage small cell lung cancer (ES-SCLC) carries a dismal prognosis. The benefit of consolidative thoracic radiotherapy (TR) after first-line chemoimmunotherapy with PD-L1 inhibitors in this setting remains unclear. As TR can improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::002dcb16ef574f43532297cfcf7ce60d
https://doi.org/10.1007/s00066-023-02075-9
https://doi.org/10.1007/s00066-023-02075-9
Publikováno v:
TumorDiagnostik & Therapie. 43:246-249
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf40ca8b80358734aee92b7991153e1e
https://doi.org/10.1055/a-1727-3032
https://doi.org/10.1055/a-1727-3032
Autor:
Mirjam Renovanz, Sylvia C Kurz, Johannes Rieger, Bianca Walter, Hannes Becker, Hanni Hille, Paula Bombach, David Rieger, Lucia Grosse, Lara Häusser, Marco Skardelly, Daniel J Merk, Frank Paulsen, Elgin Hoffmann, Cihan Gani, Manuela Neumann, Rudi Beschorner, Olaf Rieß, Cristiana Roggia, Christopher Schroeder, Stephan Ossowski, Sorin Armeanu-Ebinger, Axel Gschwind, Saskia Biskup, Martin Schulze, Falko Fend, Stephan Singer, Lars Zender, Claudia Lengerke, Sara Yvonne Brucker, Tobias Engler, Andrea Forschner, Arnulf Stenzl, Oliver Kohlbacher, Sven Nahnsen, Gisela Gabernet, Sven Fillinger, Benjamin Bender, Ulrike Ernemann, Öznur Öner, Janina Beha, Holly Sundberg Malek, Yvonne Möller, Kristina Ruhm, Marcos Tatagiba, Jens Schittenhelm, Michael Bitzer, Nisar Malek, Daniel Zips, Ghazaleh Tabatabai
Publikováno v:
Neuro-Oncology Advances. 5
BackgroundThe clinical utility of molecular profiling and targeted therapies for neuro-oncology patients outside of clinical trials is not established. We aimed at investigating feasibility and clinical utility of molecular profiling and targeted the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dca6936d44de3c026f0110a96256d048
https://doi.org/10.1093/noajnl/vdad012
https://doi.org/10.1093/noajnl/vdad012
Autor:
Elgin Hoffmann, Jürgen Honegger, Jens Schittenhelm, Johann-Martin Hempel, Marco Skardelly, Felix Behling, Christina Fodi, Ghazaleh Tabatabai, Marcos Tatagiba, Sophie Wang
Publikováno v:
Journal of Neuro-Oncology
Introduction Meningiomas are the most common benign intracranial neoplasms. CNS invasion in meningiomas has been integrated into the 2016 WHO classification of CNS tumors as a stand-alone criterion for atypia. Since then, its prognostic impact has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0574b6125064418b3549a7f6b08d967
https://doi.org/10.1007/s11060-021-03892-7
https://doi.org/10.1007/s11060-021-03892-7